From Yahoo Finance: 2025-06-16 10:50:00

McKesson Corporation (NYSE:MCK) is considered one of the best 52-week high stocks to buy by analysts, with Wells Fargo reaffirming an Equal Weight rating and $766 price target on June 10. The company raised its full-year earnings per share guidance by 0.5%, signaling potential profitability growth.

The completion of McKesson’s acquisition of a 70% controlling interest in Community Oncology Revitalization Enterprise Ventures for $2.49 billion aims to enhance community-based oncology care. Despite this strategic move, Wells Fargo remains cautious, stating the stock is adequately valued at current levels.

As a diversified healthcare services company, McKesson Corporation (NYSE:MCK) plays a key role in the pharmaceutical supply chain, offering distribution, healthcare services, and medical supplies. Its partnerships extend to biopharma companies, healthcare providers, pharmacies, manufacturers, and governments.

While McKesson shows promise as an investment, some believe certain AI stocks offer greater upside potential with less downside risk. Investors seeking undervalued AI stocks can explore opportunities that may benefit from Trump-era tariffs and the onshoring trend.



Read more at Yahoo Finance: Wells Fargo Affirms McKesson (MCK) Equal Weight Rating and $766 Price Target